Articles
All (18)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (18)
Scopus (18)
TRDizin (4)
2022
20221. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey
Yildirim F. S., User U., Sari N. D., KURTARAN B., ÖZBEL Y., Senates E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.33, no.11, pp.971-978, 2022 (SCI-Expanded)
2022
20222. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey
ÖZBEL Y., Bal T., Cabalak M., Oztoprak N. C., Sari N. D., KURTARAN B., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.33, no.10, pp.862-873, 2022 (SCI-Expanded)
2019
20193. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort
İDİLMAN R., DEMİR M., ALADAĞ M., Erol C., Cavus B., Iliaz R., et al.
JOURNAL OF VIRAL HEPATITIS
, vol.26, no.6, pp.666-674, 2019 (SCI-Expanded)
2017
20174. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines
Tabak F., Yurdaydin C., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.28, 2017 (SCI-Expanded)
2017
20175. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines
Yurdaydin C., Tabak F., KAYMAKOĞLU S., Tabak F., AKARSU M., Akinci E. G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.28, 2017 (SCI-Expanded)
2016
20166. Changes in HIV demographic patterns in a low prevalence population: no evidence of a shift towards men who have sex with men
Sargin F., Yildiz D., Aydin O. A., Mete B., Gunduz A., Karaosmanoglu H. K., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, vol.48, pp.52-56, 2016 (SCI-Expanded)
2015
20157. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease
OZTURK O., COLAK Y., SENATES E., YILMAZ Y., ULASOGLU C., DOGANAY L., et al.
WORLD JOURNAL OF GASTROENTEROLOGY
, vol.21, no.26, pp.8096-8102, 2015 (SCI-Expanded)
2015
20158. Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients
Meric K., Bakal N., Senates E., Aydin S., Kilicoglu Z. G., Ulger F. E. B., et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE
, 2015 (SCI-Expanded)
2014
20149. First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment
Ozaras R., Mete B., Ceylan B., Ozgunes N., Gunduz A., Karaosmanoglu H., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, vol.26, no.7, pp.774-780, 2014 (SCI-Expanded)
2013
201310. Assessment of endothelial function in patients with nonalcoholic fatty liver disease
ÇOLAK Y., ŞENATEŞ E., YEŞİL A., YILMAZ Y., ÖZTÜRK O., DOĞANAY L., et al.
ENDOCRINE
, vol.43, no.1, pp.100-107, 2013 (SCI-Expanded)
2013
201311. SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION
Sahin O., Yesil A., Senates E., Akdogan M. F., Konur S., Erdem E., et al.
ACTA MEDICA MEDITERRANEA
, vol.29, no.3, pp.569-573, 2013 (SCI-Expanded)
2012
201212. Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome
Tabak O., Gelisgen R., Cicekci H., Senates E., Erdenen F., Muderrisoglu C., et al.
MINERVA MEDICA
, vol.103, no.4, pp.323-329, 2012 (SCI-Expanded)
2012
201213. Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease
COLAK Y., SENATES E., OZTURK O., DOGANAY H. L., Coskunpinar E. M., Oltulu Y. M., et al.
METABOLIC SYNDROME AND RELATED DISORDERS
, vol.10, no.2, pp.103-109, 2012 (SCI-Expanded)
2011
201114. Collagenous Colitis: A Retrospective Survey of Patients with Chronic Diarrhea
Hatemi A. I., Senates E., Dobrucali A. M., Goksel S.
HEPATO-GASTROENTEROLOGY
, vol.58, no.112, pp.1963-1967, 2011 (SCI-Expanded)
2011
201115. Plasma Fibrinogen-Like Protein 2 Levels in Patients with Non-Alcoholic Fatty Liver Disease
COLAK Y., SENATES E., ÖZTÜRK O., YILMAZ Y., Coskunpinar E., Kahraman O. T., et al.
HEPATO-GASTROENTEROLOGY
, vol.58, no.112, pp.2087-2090, 2011 (SCI-Expanded)
2011
201116. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
YILMAZ Y., Kurt R., Gurdal A., ÖZEN ALAHDAB Y., Yonal O., Senates E., et al.
ATHEROSCLEROSIS
, vol.217, no.1, pp.125-129, 2011 (SCI-Expanded)
2010
201017. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism
Calhan T., Senates E., Cebeci E., Zuhur S. S., Ozbakir F., Gorpe U.
ENDOCRINE
, vol.38, no.2, pp.199-205, 2010 (SCI-Expanded)
2010
201018. A TWIN STUDY IN BEHCET'S SYNDROME
Masatlioglu S., Seyahi E., Tahir Turanlı E., Fresko I., Gogus F., Senates E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, vol.28, no.4, 2010 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2013
20131. Evaluation of gallbladder kinetics in patients with nonalcoholic fatty liver disease
Colak Y., Bozbey G., Senates E., Doganay L., Coskunpinar E., Ozturk O., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 November 2013, vol.58, (Summary Text)
2012
20122. Entecavair versus tenofovir in treatment-naive chronic Hepatitis B patients: Real-world data from the realist* study
Mete B., Ceylan B., Ozgunes N., Gunduz A., Karaosmanoglu H. K., Cagatay A., et al.
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 9 - 13 November 2012, vol.56